Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan

Tomohiko Harada, Yoshihiro Noguchi, Ai Ohnishi, Rikuto Masuda, Tomoya Sugimoto, Tomoaki Yoshimura

Open source

DOI
10.1007/s40801-026-00582-6
Published
2026-09-17
Container
Drugs - Real World Outcomes
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40801-026-00582-6,
  title = {Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan},
  author = {Tomohiko Harada and Yoshihiro Noguchi and Ai Ohnishi and Rikuto Masuda and Tomoya Sugimoto and Tomoaki Yoshimura},
  year = {2026},
  journal = {Drugs - Real World Outcomes},
  doi = {10.1007/s40801-026-00582-6},
  url = {https://doi.org/10.1007/s40801-026-00582-6}
}

RIS

TY  - JOUR
TI  - Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan
AU  - Tomohiko Harada
AU  - Yoshihiro Noguchi
AU  - Ai Ohnishi
AU  - Rikuto Masuda
AU  - Tomoya Sugimoto
AU  - Tomoaki Yoshimura
PY  - 2026
JO  - Drugs - Real World Outcomes
DO  - 10.1007/s40801-026-00582-6
UR  - https://doi.org/10.1007/s40801-026-00582-6
ER  - 

APA

Harada, T., Noguchi, Y., Ohnishi, A., Masuda, R., Sugimoto, T., & Yoshimura, T. (2026). Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan. Drugs - Real World Outcomes. https://doi.org/10.1007/s40801-026-00582-6

Source records